Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer
Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength ...
Mar 23, 2012
0
0